Dimethyl Sulfoxide PDE report and OEL report profile
Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
67-68-5
Molecular formula
C2H6OS
Molecular weight
78.133 g/mol
Drug class
Polar aprotic solventtopical and intravesical medicinal agent with anti-inflammatory/analgesic properties
Mechanism of action
Has solvent and membrane-penetration properties and can modulate inflammatory and nociceptive pathways; the mechanism underlying clinical benefit in interstitial cystitis is not fully understood.
Indications / reported uses
Intravesical treatment of interstitial cystitis/bladder pain syndrome in adults using the authorised 50% DMSO bladder instillation product; other topical or industrial uses are not equivalent to this medicinal indication
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Dimethyl Sulfoxide PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Dimethyl Sulfoxide Permitted Daily Exposure (PDE) report (the Dimethyl Sulfoxide PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Dimethyl Sulfoxide Occupational Exposure Limit (OEL) report (the Dimethyl Sulfoxide OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.